Le Lézard
Classified in: Health, Science and technology
Subject: Conference Calls/ Webcasts

CohBar to Announce 2022 Second Quarter Financial Results and Provide Business Update on August 15, 2022


MENLO PARK, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company leveraging the power of the mitochondria and the peptides encoded in its genome to develop potential breakthrough therapeutics targeting chronic and age-related diseases, announced today that the company will release its 2022 second quarter financial results after the market closes on Monday, August 15, 2022. Management will host a conference call and webcast at 5:00 p.m. ET (2:00 p.m. PT) on the same day to provide an update on the company's business.

Details for the Conference Call:

Date: August 15, 2022
Time: 5:00 p.m. ET (2:00 p.m. PT)

Conference Audio

Webcast

For individuals participating in the Investor Call or webcast, please call or login to the conference audio approximately 10 minutes prior to its start.

An audio replay of the call will be available beginning at 8:00 p.m. Eastern Time on August 15, 2022, through 11:59 p.m. Eastern Time on September 5, 2022. To access the recording please dial (844) 512-2921 in the U.S. and Canada, or (412) 317-6671 internationally, and reference Conference ID# 13730421. The audio recording will also be available at www.cohbar.com during the same period.

About CohBar

CohBar (NASDAQ: CWBR) is a clinical-stage biotechnology company leveraging the power of the mitochondria and the peptides encoded in its genome to develop potential breakthrough therapeutics targeting chronic and age-related diseases with limited to no treatment options. CohBar has assembled the leading position in exploring the mitochondrial genome and its utility for the development of novel therapeutics, including world-renowned expertise in mitochondrial biology, a broad intellectual property estate, key opinion leaders and disciplined drug discovery and development processes. CohBar is utilizing its Mito+ platform to identify and develop modified versions of natural peptides called analogs to treat a variety of serious conditions, with a focus on diseases involving inflammation and fibrosis.

For additional company information, please visit www.cohbar.com and engage with us on LinkedIn.

Contacts:

Jordyn Tarazi
Director of Investor Relations
CohBar, Inc.
(650) 445-4441
[email protected]



These press releases may also interest you

at 11:00
States with Highest COVID-19 Vaccination Rates Showed Steepest Decline in Pediatric Asthma Prevalence
States with high rates of COVID-19 vaccination saw more pediatric asthma patients get a break from their symptoms, according to new research published today in JAMA Network Open by leaders from Nemours Children's Health and Endeavor Health....

at 10:57
Terminix Announces National United Soccer League Ticket Giveaway
Terminix®, a Rentokil Terminix company, is thrilled to announce an exciting national ticket giveaway for fans of USL Championship and League One soccer. The "Terminix It for Tickets" sweepstakes aims to celebrate the passion of soccer fans across the...

at 10:55
Gynecology Collaboration and Licensing Agreements Analysis Report 2024 with Directory of Deals Signed by the World's Leading Life Science Companies Since 2016 - ResearchAndMarkets.com
The "Gynecology Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Gynecology Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the gynecology...

at 10:50
Evive Brands Continues Q2 Steady Growth with 12 New Franchise Agreements
Evive Brands, a leader in the health and home services sector, today announced continued expansion in the second quarter of 2024, signing 12 new franchise agreements across its portfolio. The community of premier franchise brands includes Assisted...

at 10:45
Lung Health Foundation Appoints Donna Cansfield As New Chair of Board of Directors
The Lung Health Foundation (LHF) (lunghealth.ca), Canada's leading non-profit lung health organization, today announced new appointments to its Board of Directors, reinforcing its commitment to improving lung health for all Canadians. Donna Cansfield...

at 10:35
Appeal launched to support people impacted by Hurricane Beryl
The Canadian Red Cross has launched the Hurricane Beryl Appeal to help those affected by the hurricane. The Red Cross is working to help those impacted by Hurricane Beryl in the Caribbean region as quickly as possible. Money raised will enable the...

More news about Health...


News published on and distributed by: